MDM2 and cancer: Interestingly, a pan-cancer RNA editing study highlighted that the 3′ UTR of the Mouse double minute 2 homolog (MDM2) oncogene underwent A-to I editing in 11 out of the 14 cancer types investigated within a region of the 3′ UTR complementary to the miR-200 “seed” region.